4.8200
0.0000
(0.00%)
At close: January 10 at 5:36:04 PM GMT+1
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Philip Schetter | Chief Executive Officer | -- | -- | -- |
| Mr. Bernhard Retzer | Global Director of Sales | -- | -- | -- |
Cantourage Group SE
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
Description
Cantourage Group SE operates as a medical cannabis company in Europe. It offers dried flowers, extracts, dronabinol products, and pharma-grade cannabidiol products. The company was founded in 2019 and is based in Kleinmachnow, Germany.
Corporate Governance
Cantourage Group SE’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
H6D0.DE Haleon plc
4.4650
-3.12%
ZOE.DE Zoetis Inc.
160.64
+0.59%
27N0.DE CANNOVUM CANNABIS AG I
0.5300
+0.95%
B8FK.DE Biofrontera AG
2.2700
0.00%
BXT.DE BioNxt Solutions Inc.
0.2630
-3.66%
VIA.DE Viatris Inc.
11.36
-1.65%
APPH.DE Apontis Pharma AG
10.20
+0.99%
PSG.DE PharmaSGP Holding SE
26.80
+0.75%
2HQ.DE Tilray Brands, Inc.
1.1715
-10.26%
DMP.DE Dermapharm Holding SE
40.05
+0.63%